The BMPR1B Gene Chondrodysplasia Acromesomelic with Genital Anomalies Genetic Test is a specialized diagnostic tool designed to identify mutations in the BMPR1B gene, which are linked to a rare genetic disorder. This condition is characterized by severe shortening of the limbs (acromesomelic chondrodysplasia) and may also include genital anomalies. These mutations interfere with bone growth and development, leading to the physical manifestations associated with the disorder.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test provides crucial information for the diagnosis and management of affected individuals. By analyzing a sample of the patient's DNA, the test can detect specific genetic alterations in the BMPR1B gene, confirming the diagnosis and allowing for personalized treatment plans.
The cost of the BMPR1B Gene Chondrodysplasia Acromesomelic with Genital Anomalies Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to identify the genetic mutation responsible for the condition, offering families and healthcare providers valuable insights into the patient's condition and guiding future medical care.
The GPSM2 Gene Chudley-McCullough Syndrome Genetic Test is a specialized diagnostic tool used to identify mutations in the GPSM2 gene, which are associated with Chudley-McCullough Syndrome. This condition is a rare genetic disorder characterized by sensorineural hearing loss and brain abnormalities, potentially leading to developmental delays and other neurological issues. The test involves analyzing the patient's DNA to detect specific genetic alterations in the GPSM2 gene that are indicative of the syndrome.
Performed at DNA Labs UAE, a leading facility in genetic testing and diagnostics, the test offers a reliable means for clinicians to diagnose Chudley-McCullough Syndrome accurately. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to interpret the results accurately. Identifying the genetic basis of the syndrome through this test can significantly aid in managing the condition, allowing for targeted interventions and support for affected individuals and their families.
The ERCC6L2 Gene Bone Marrow Failure Syndrome Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the ERCC6L2 gene, which are associated with Bone Marrow Failure Syndrome Type 2. This condition is a rare genetic disorder that can lead to serious complications including anemia, increased risk of infections, and a higher likelihood of developing leukemia. Early and accurate diagnosis through this genetic test enables healthcare providers to tailor treatment plans more effectively, improving patient outcomes.
The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory for specific genetic alterations in the ERCC6L2 gene. The results of this test can provide crucial information for the management of the condition, including guidance on monitoring strategies and treatment options to address the symptoms and prevent complications. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the accuracy and reliability of the test results, making it a trusted choice for patients and healthcare providers seeking comprehensive insights into Bone Marrow Failure Syndrome Type 2.
The GDF5 gene, associated with the development and maintenance of bone and cartilage, plays a crucial role in the skeletal system's growth. Mutations in the GDF5 gene can lead to various skeletal disorders, including Brachydactyly Type A1C, a condition characterized by the shortening of bones in the fingers and toes. This specific type of brachydactyly can affect an individual's dexterity and overall hand and foot functionality.
To diagnose Brachydactyly Type A1C, a genetic test targeting the GDF5 gene can be conducted. This test is designed to identify mutations in the GDF5 gene that are responsible for the condition. DNA Labs UAE offers this specialized genetic test, providing a crucial tool for individuals seeking to understand their genetic makeup and the risk of passing the condition to their offspring. The test is priced at 4400 AED, reflecting the comprehensive analysis and detailed results it provides.
Undergoing this test at DNA Labs UAE involves a simple procedure, typically requiring a blood sample or cheek swab from the patient. The lab uses advanced genetic sequencing technologies to analyze the sample, focusing on the GDF5 gene to detect any mutations associated with Brachydactyly Type A1C. The results of this test can offer valuable insights for affected individuals and their families, guiding decisions regarding management, treatment options, and genetic counseling.
The BMP2 gene Brachydactyly Type A2 genetic test is a specialized diagnostic procedure designed to identify mutations in the BMP2 gene, which are responsible for causing Brachydactyly Type A2. This condition is characterized by the shortening of the bones in the fingers, leading to significantly shorter than normal fingers and potentially impacting hand function. The BMP2 gene plays a crucial role in the development of bones and cartilage, making its mutation a key factor in the onset of this condition.
Performed at DNA Labs UAE, this test is a critical tool for individuals seeking to understand their genetic predisposition to Brachydactyly Type A2. It involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of specific mutations in the BMP2 gene.
The cost of the BMP2 gene Brachydactyly Type A2 genetic test is 4400 AED. This price reflects the specialized nature of the test, including the expertise required to accurately identify and interpret the genetic mutations associated with the condition. Upon completion, the test provides valuable insights that can inform decisions about management and treatment options, offering a personalized approach to care for individuals with or at risk of developing Brachydactyly Type A2.
The BMPR1B gene plays a crucial role in skeletal development and is associated with Brachydactyly Type A2, a condition characterized by shortening of the bones in the fingers, leading to abnormally short fingers and toes. A genetic test for Brachydactyly Type A2 through the analysis of the BMPR1B gene can provide vital information for individuals showing symptoms or having a family history of this condition. Conducted at DNA Labs UAE, this specialized test is priced at 4400 AED. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, and examining it for specific mutations in the BMPR1B gene that are known to cause Brachydactyly Type A2. This test is essential for accurate diagnosis, guiding treatment options, and understanding the risk of passing the condition to future generations.
The "ROR2 Gene Brachydactyly Type B1 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the ROR2 gene, which are linked to Brachydactyly Type B1 - a rare genetic condition characterized by the shortening or absence of the bones in the fingers and toes. This test is crucial for individuals showing symptoms of the condition or those with a family history, as it helps in confirming the diagnosis, understanding the risk of passing it to offspring, and aiding in the management of the condition. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test ensures accuracy and confidentiality. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting provided.
The HOXD13 Gene Brachydactyly Type E1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the HOXD13 gene, which are associated with Brachydactyly Type E1. This condition is characterized by the shortening of bones in the hands and feet, affecting the overall length and functionality of the digits. The test is crucial for individuals with a family history of the condition or those exhibiting symptoms, as it aids in accurate diagnosis, guiding treatment options, and genetic counseling. Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific genetic alterations in the HOXD13 gene. Results from this test can provide valuable insights into the genetic underpinnings of Brachydactyly Type E1, enabling targeted interventions and support for affected individuals and their families.
The HDAC4 Gene Brachydactyly-Mental Retardation Syndrome Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the HDAC4 gene which are associated with Brachydactyly-Mental Retardation Syndrome (BDMR). This condition is characterized by shortened fingers and toes (brachydactyly) along with intellectual disabilities and sometimes other physical and developmental challenges. The test plays a crucial role in the early diagnosis and management of BDMR, enabling healthcare professionals to devise personalized treatment and intervention strategies for affected individuals.
Performed through a detailed analysis of the patient's genetic material, the test looks for specific alterations in the HDAC4 gene that have been linked to the syndrome. The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into the genetic underpinnings of BDMR, facilitating informed decisions regarding care and support.
The HOXD13 Gene Brachydactyly-Syndactyly Syndrome Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the HOXD13 gene, which are linked to the development of Brachydactyly-Syndactyly Syndrome. This condition is characterized by abnormalities in the fingers and toes, including shortened digits (brachydactyly) and fused digits (syndactyly), which can affect both the functionality and appearance of the hands and feet. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect specific genetic alterations in the HOXD13 gene, providing valuable information for diagnosis, treatment planning, and genetic counseling. This test is crucial for families with a history of the syndrome, offering insights into inheritance patterns and risk assessments for future generations. DNA Labs UAE employs state-of-the-art genetic testing technologies to ensure accurate and reliable results, making it a trusted choice for individuals seeking comprehensive genetic analysis.
